|
|
Volumn 6, Issue 4, 2000, Pages 171-176
|
|
Phase I, randomized, double-blind trial of 7-allyl-8-oxoguanosine (loxoribine) in advanced cancer
|
|
Author keywords
Guanine ribonucleosides; Immunomodulators; Loxoribine; Phase I trials
|
|
Indexed keywords
LOXORIBINE;
PLACEBO;
DRUG DERIVATIVE;
GUANOSINE;
IMMUNOLOGICAL ADJUVANT;
ADULT;
ADVANCED CANCER;
AGED;
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY;
ARTICLE;
CHILL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG SAFETY;
DRUG STRUCTURE;
FEMALE;
FEVER;
FLUSHING;
HEADACHE;
HUMAN;
INFLAMMATION;
LUNG EMBOLISM;
LYMPHOKINE ACTIVATED KILLER CELL;
MALE;
NAUSEA AND VOMITING;
PAIN;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RASH;
CELL CULTURE;
CHEMICAL MODEL;
DISEASE COURSE;
DOSE RESPONSE;
LYMPHOCYTE;
METABOLISM;
MIDDLE AGED;
MONONUCLEAR CELL;
NATURAL KILLER CELL;
NEOPLASM;
TIME;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
AGED;
DISEASE PROGRESSION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
GUANOSINE;
HUMANS;
KILLER CELLS, NATURAL;
LEUKOCYTES, MONONUCLEAR;
LYMPHOCYTES;
MALE;
MIDDLE AGED;
MODELS, CHEMICAL;
NEOPLASMS;
TIME FACTORS;
TUMOR CELLS, CULTURED;
|
|
EID: 0034351121
PISSN: 13684736
EISSN: None
Source Type: Journal
DOI: 10.1080/mccm.6.4.171.176 Document Type: Article |
|
Times cited : (21)
|
|
References (12)
|
